Robert P. Whitehead
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 5
- Pancreatic and Hepatic Oncology Research 4
- Colorectal Cancer Treatments and Studies 3
-
- Immunotherapy and Immune Responses 5
- Co-authors
- James L. Abbruzzese (6 shared papers)Sheryl McCoy (3 shared papers)Syma Iqbal (2 shared papers)John Smyth Macdonald (7 shared papers)E. David Crawford (2 shared papers)Geoffrey R. Weiss (2 shared papers)James Lloyd Wade (1 shared paper)Phyllis J. Goodman (3 shared papers)
- Journals
- Investigational New Drugs (10 papers)Journal of Immunotherapy (5 papers)JNCI Journal of the National Cancer Institute (2 papers)Cancer (2 papers)The Journal of Urology (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Robert P. Whitehead
44 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 87
- Oncology 544
- Cancer Research 182
- Immunology 226
- Pulmonary and Respiratory Medicine 208
- Molecular Biology 310
Countries citing papers authored by Robert P. Whitehead
This map shows the geographic impact of Robert P. Whitehead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Whitehead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Whitehead more than expected).
Fields of papers citing papers by Robert P. Whitehead
This network shows the impact of papers produced by Robert P. Whitehead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Whitehead. The network helps show where Robert P. Whitehead may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert P. Whitehead, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 130 | |
| 2 | 2005 | 120 | |
| 3 | 1990 | 85 | |
| 4 | 2014 | 77 | |
| 5 | 2008 | 73 | |
| 6 | 1997 | 70 | |
| 7 | 2006 | 58 | |
| 8 | 1991 | 55 | |
| 9 | Subcutaneous recombinant interleukin 2 in a dose escalating regimen in patients with metastatic renal cell adenocarcinoma. | 1990 | 49 |
| 10 | 1991 | 42 | |
| 11 | 2002 | 39 | |
| 12 | 1998 | 38 | |
| 13 | 2015 | 32 | |
| 14 | 1993 | 24 | |
| 15 | A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study. | 1990 | 24 |
| 16 | 1995 | 23 | |
| 17 | 2004 | 20 | |
| 18 | 2002 | 18 | |
| 19 | 2006 | 13 | |
| 20 | 1997 | 13 |
About Robert P. Whitehead
Robert P. Whitehead is a scholar working on Oncology, Immunology, Architecture, Cancer Research and Visual Arts and Performing Arts, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Design Education and Practice (4 papers), Cancer Genomics and Diagnostics (3 papers), Structural Engineering and Vibration Analysis (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (544 citations), Cancer Research (182 citations), Immunology (226 citations), Pulmonary and Respiratory Medicine (208 citations) and Molecular Biology (310 citations). Robert P. Whitehead has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include James L. Abbruzzese, Sheryl McCoy, Syma Iqbal, John Smyth Macdonald, E. David Crawford, Geoffrey R. Weiss, James Lloyd Wade, Phyllis J. Goodman, Jeffrey Kent Giguere and Evan M. Hersh. Their work appears in journals such as Investigational New Drugs, Journal of Immunotherapy, JNCI Journal of the National Cancer Institute, Cancer and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.